Table 2.
Sample | α | ω | ECV | ωh |
---|---|---|---|---|
AUS | 0.95 | 0.96 | 0.90 | 0.84 |
CAN | 0.92 | 0.94 | 0.89 | 0.81 |
CH | 0.95 | 0.97 | 0.92 | 0.89 |
ISR | 0.90 | 0.93 | 0.79 | 0.71 |
ITA | 0.92 | 0.94 | 0.87 | 0.80 |
JAP | 0.90 | 0.95 | 0.88 | 0.83 |
NL | 0.91 | 0.93 | 0.87 | 0.77 |
POR | 0.92 | 0.94 | 0.85 | 0.80 |
SVK | 0.90 | 0.94 | 0.85 | 0.79 |
TAI | 0.93 | 0.94 | 0.91 | 0.85 |
UK1 | 0.94 | 0.95 | 0.90 | 0.84 |
UK2 | 0.93 | 0.94 | 0.87 | 0.79 |
USA | 0.93 | 0.94 | 0.86 | 0.80 |
AUS Australia (N = 319); CAN Canada (N = 383); CH Switzerland (N = 230); ISR Israel (N = 476); ITA Italy (N = 389); JAP Japan (N = 264); NL Netherlands (N = 360); POR Portugal (N = 764); SVK Slovakia (N = 1326); TAI Taiwan (N = 417); UK1 United Kingdom 1 (N = 1570); UK2 United Kingdom 2 (N = 883) and USA (N = 331)